Gryt is a proven partner in research and RWE studies that drive results.
Since 2017, Gryt has been a full-service Ad Board and Patient Experience research partner.
We deliver results that optimize trial recruitment and refine Advocacy and Commercial strategy.
Examples of our work include:
-
Center for Observational Research
Co-developed protocol and led study activities for 200 patients with solid tumor and MM to under patient awareness of cancer-related bone health and to identify opportunities to improve bone health education in cancer patients at risk of SREs for XGEVA
-
Global Patient Affairs
Roundtables with systemic mastocytosis patients
-
Early Pipeline / HEOR
Focus groups with bladder cancer patients on burden of illness and potential PRO’s for a trial
-
Patient Advocacy/ Global Market Insights/HEOR
12 SoW’s from 2017 – 2023 to drive Advocacy and Commercialization strategy and activities for ADCETRIS, resulting in 7 posters and peer-reviewed publications.
-
Oncology Therapeutic Strategy and Innovation
CAR T research and publication with patients considering and undergoing CAR T treatment
-
Patient Marketing
Ad Boards with mCRC patients to understand their needs, goals, and habits around their disease, with a focus on refining and aligning promotional campaign materials and defining the product brand for fruquintinib
Case Study: RWE research, strategy, and dissemination
Amgen’s XGEEVA team came to Gryt with questions about bone health in cancer patients that required answers from the patients themselves, rather than doctors or the healthcare system.
Gryt worked with Amgen to design the BonE heAlth eduCatiOn Needs assessment (BEACON), a survey of multiple myeloma and bone metastatic solid tumor patients at risk for skeletal-related events. Gryt led IRB approvals, recruiting, analysis, recommendations & publication
“I think your company’s platform is unique and will undoubtedly improve both the OS and QoL for patients. Results from the BEACON project will be used to form the basis for meaningful scientific exchange towards awareness of an ongoing medical need (which can be addressed with available therapies!).”